25周年を記念 1999-2024
*3年間で¥ 153396、たったの¥ 61358
フォローフィードコミュニティでトレーダーや投資家とつながりましょう.
包括的なオプション データを調査し、オプション フローで高度なフィルターを使用します.
ターミナル モニターで株式と資産のウォッチリストを整理および監視します
Labs Are Vital, Channel One Network competition reaches 2.2 million high school students CHICAGO, July 21 /PRNewswire-FirstCall/ -- Labs Are...
Broad Size Matrix of XIENCE PRIME to be Launched in Europe in the Third Quarter ABBOTT PARK, Ill., June 23 /PRNewswire-FirstCall/ -- Abbott...
ABBOTT PARK, Ill., June 12 /PRNewswire-FirstCall/ -- The board of directors of Abbott today declared a quarterly common dividend of 40 cents per...
ABBOTT PARK, Ill., June 1 /PRNewswire-FirstCall/ -- Abbott will present at the Goldman Sachs 30th Annual Global Healthcare Conference on...
The Scientist Magazine Recognizes Abbott as One of the Best Places to Work in Industry ABBOTT PARK, Ill., May 29 /PRNewswire-FirstCall/...
Company's Report Outlines Strategic Citizenship Priorities: Innovating for the Future, Enhancing Access, Safeguarding the Environment and...
ABBOTT PARK, Ill., April 24 /PRNewswire-FirstCall/ -- Abbott's diversified portfolio of businesses generated industry-leading results across the...
In SPIRIT II Trial, XIENCE V Drug Eluting Stent Demonstrates Clinically Meaningful Reductions Compared to TAXUS in Key Safety Endpoints, Including...
Data Demonstrate Bioabsorbable Stent Is Absorbed Within Two Years, Leaving Behind Blood Vessels that Appear to Move and Function Similar to...
ABBOTT PARK, Ill., March 4 /PRNewswire-FirstCall/ -- Abbott will present at the Cowen and Company 29th Annual Health Care Conference on Tuesday...
ABBOTT PARK, Ill., Feb. 25 /PRNewswire-FirstCall/ -- Abbott today announced the successful completion of the tender offer by its wholly owned...
COLUMBUS, Ohio, Feb. 16 /PRNewswire/ -- Abbott Nutrition today announced that it is initiating a precautionary, voluntary recall of...
COLUMBUS, Ohio, Jan. 19 /PRNewswire-FirstCall/ -- Abbott Nutrition today announced that it is initiating a precautionary, voluntary recall of...
Latest Waiver Covers Cartridges For 6+, E3+, EC4+, Creatinine and Glucose PRINCETON, N.J., Jan. 19 /PRNewswire-FirstCall/ -- Abbott announced...
ご覧いただいた銘柄が下記のボックス内に表示されますので、過去閲覧した銘柄情報に簡単にアクセスすることができます。
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約